ZA200700477B - 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri(hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors - Google Patents
1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri(hetero) aryl-2-heterocyclylethanes as potassium channel inhibitorsInfo
- Publication number
- ZA200700477B ZA200700477B ZA200700477A ZA200700477A ZA200700477B ZA 200700477 B ZA200700477 B ZA 200700477B ZA 200700477 A ZA200700477 A ZA 200700477A ZA 200700477 A ZA200700477 A ZA 200700477A ZA 200700477 B ZA200700477 B ZA 200700477B
- Authority
- ZA
- South Africa
- Prior art keywords
- hetero
- heterocyclylethanes
- arylethanes
- tetra
- tri
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59218104P | 2004-07-29 | 2004-07-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200700477B true ZA200700477B (en) | 2009-08-26 |
Family
ID=35613661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200700477A ZA200700477B (en) | 2004-07-29 | 2007-01-16 | 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri(hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors |
Country Status (15)
Country | Link |
---|---|
KR (1) | KR20070043985A (xx) |
AR (1) | AR049847A1 (xx) |
BR (1) | BRPI0513793A (xx) |
CR (1) | CR8876A (xx) |
EC (1) | ECSP077208A (xx) |
IL (1) | IL180846A0 (xx) |
MA (1) | MA28980B1 (xx) |
MX (1) | MX2007001188A (xx) |
NO (1) | NO20071107L (xx) |
PE (1) | PE20060382A1 (xx) |
RU (1) | RU2344134C2 (xx) |
TW (1) | TW200607493A (xx) |
UA (1) | UA88018C2 (xx) |
WO (1) | WO2006028590A1 (xx) |
ZA (1) | ZA200700477B (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI1009313A2 (pt) * | 2009-03-18 | 2018-01-30 | Medicure Int Inc | preparação farmacêutica transdérmica e administração de tirofiban |
BR112014030629B1 (pt) | 2012-06-11 | 2021-12-21 | Bristol-Myers Squibb Company | Prófármacos de ácido fosforamídico de 5-[5-fenil-4-(piridin-2-ilmetilamino) quinazolin -2-il] piridina-3-sulfonamida e composição farmacêutica que os compreende |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003059873A1 (en) * | 2002-01-04 | 2003-07-24 | Poseidon Pharmaceuticals A/S | Potassium channel modulators |
-
2005
- 2005-07-19 AR ARP050102975A patent/AR049847A1/es unknown
- 2005-07-22 PE PE2005000858A patent/PE20060382A1/es not_active Application Discontinuation
- 2005-07-22 TW TW094125011A patent/TW200607493A/zh unknown
- 2005-07-25 KR KR1020077002228A patent/KR20070043985A/ko not_active Application Discontinuation
- 2005-07-25 RU RU2007107408/04A patent/RU2344134C2/ru not_active IP Right Cessation
- 2005-07-25 WO PCT/US2005/026334 patent/WO2006028590A1/en active Application Filing
- 2005-07-25 UA UAA200702125A patent/UA88018C2/ru unknown
- 2005-07-25 BR BRPI0513793-4A patent/BRPI0513793A/pt not_active IP Right Cessation
- 2005-07-25 MX MX2007001188A patent/MX2007001188A/es unknown
-
2007
- 2007-01-16 ZA ZA200700477A patent/ZA200700477B/xx unknown
- 2007-01-21 IL IL180846A patent/IL180846A0/en unknown
- 2007-01-25 CR CR8876A patent/CR8876A/es not_active Application Discontinuation
- 2007-01-26 EC EC2007007208A patent/ECSP077208A/es unknown
- 2007-02-21 MA MA29689A patent/MA28980B1/fr unknown
- 2007-02-27 NO NO20071107A patent/NO20071107L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2007107408A (ru) | 2008-09-10 |
BRPI0513793A (pt) | 2008-05-13 |
UA88018C2 (ru) | 2009-09-10 |
AR049847A1 (es) | 2006-09-06 |
MX2007001188A (es) | 2007-03-21 |
KR20070043985A (ko) | 2007-04-26 |
PE20060382A1 (es) | 2006-05-15 |
WO2006028590A1 (en) | 2006-03-16 |
CR8876A (es) | 2007-08-28 |
IL180846A0 (en) | 2007-06-03 |
MA28980B1 (fr) | 2007-11-01 |
TW200607493A (en) | 2006-03-01 |
RU2344134C2 (ru) | 2009-01-20 |
ECSP077208A (es) | 2007-02-28 |
NO20071107L (no) | 2007-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200407666B (en) | Pyridinoylpiperidines as 5-HTif agonists. | |
HK1209729A1 (en) | Compounds, compositions and methods | |
EP1781635A4 (en) | POTASSIUM CHANNEL INHIBITORS | |
ZA200610142B (en) | Furanopyrimidine compounds effective as potassium channel inhibitors | |
AP2321A (en) | Quinoline derivatives for use as mycobactrial inhibitor. | |
TWI369351B (en) | 2,4-diamino-pyrimidines as aurora inhibitors | |
AP2280A (en) | Compositions and methods for increasing telomeraseactivity. | |
ZA200502210B (en) | Substrates for O6-alkylguanine-DNA alkyltansferase. | |
HK1102583A1 (en) | Sulphonylpyrroles as hdac inhibitors | |
IL183706A0 (en) | 2,4(4,6) pyrimidine derivatives | |
EP1667683A4 (en) | INHIBITORS OF POTASSIUM CHANNELS WITH QUINOLINE | |
WO2006009649A3 (en) | Brassica indehiscent1 sequences | |
EP1940406A4 (en) | POTASSIUM CHANNEL INHIBITORS | |
WO2007062308A3 (en) | Homo- and heterocyclic compounds suitable as cetp inhibitors | |
EP1493437A4 (en) | COMPOSITIONS AGAINST DIABETES | |
ZA200307420B (en) | Point chisel. | |
ZA200805028B (en) | Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors | |
AU2003212310A1 (en) | (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors | |
HK1115878A1 (en) | (2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors | |
EP1776355A4 (en) | POTASSIUM CHANNEL INHIBITORS | |
ZA201005087B (en) | 4-imidazolidinones as kv1.5 potassium channel inhibitors | |
EP1667973A4 (en) | INHIBITORS OF THE QUINOLINE POTASSIUM CANAL | |
EP1723145A4 (en) | SUBSTITUTED 5,12-DIAZENZOANTHRACENANALOGA | |
IL180846A0 (en) | 1,1,2,2-tetra (hetero) arylethanes or 1,1,2-tri (hetero) aryl-2-heterocyclylethanes as potassium channel inhibitors | |
ZA201005086B (en) | 4-imidazolidinones as kv1.5 potassium channel inhibitors |